Cytokinetics (NASDAQ:CYTK) Price Target Lowered to $84.00 at Mizuho
Cytokinetics (NASDAQ:CYTK – Get Free Report) had its price target decreased by research analysts at Mizuho from $103.00 to $84.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Mizuho’s price target suggests a potential upside of 172.02% from the stock’s previous close. Other […]
Cytokinetics (NASDAQ:CYTK – Get Free Report) had its price target decreased by research analysts at Mizuho from $103.00 to $84.00 in a research note issued on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Mizuho’s price target suggests a potential upside of 172.02% from the stock’s previous close. Other […]
